Clinical Trial

Efficacy, Safety, and Tolerability of 4-MUST Tablets in Chronic Cholecystitis and Biliary Dyskinesia

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This study aims to evaluate the efficacy, safety, and tolerability of the drug 4-MUST at various doses compared to placebo in patients with chronic cholecystitis and biliary dyskinesia
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-02-17; most recent amendment 2025-07-07.
Trial Details
NCT Number NCT06842966
Lead Sponsor Valenta Pharm JSC
Conditions Chronic Cholecystitis, Biliary Dyskinesia
Enrollment 300 participants
Start Date 2024-10-17
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-07-11